Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) is now available.
MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders affecting drug licenses for retail pharmacy stores in Telangana and Maharashtra. The Jawahar Nagar store in Telangana faces a three-day license suspension ordered by the Assistant Director of the Drugs Control Administration, while the Radha Nagar-Kalyan store in Maharashtra faces a seven-day suspension ordered by the Food and Drug Administration, Mumbai; together, the suspensions are expected to result in a potential revenue loss of about Rs 5.54 lakh but are not indicated to materially disrupt the company’s overall operations.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited operates in the healthcare and pharmacy retail sector in India, offering pharmaceutical products and related health solutions through its network of stores. The company serves customers across multiple states, with operations conducted both directly and through subsidiaries such as Optival Health Solutions Private Limited.
Average Trading Volume: 21,708
Technical Sentiment Signal: Strong Buy
Current Market Cap: 97.61B INR
For an in-depth examination of MEDPLUS stock, go to TipRanks’ Overview page.